Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Paola Rogliani & Mario Cazzola. (2021) Sex differences in COPD management. Expert Review of Clinical Pharmacology 14:3, pages 323-332.
Read now
Read now
Angely Loubert, Antoine Regnault, Juliette Meunier, Florian S Gutzwiller & Stéphane A Regnier. (2020) Is the St. George’s Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2103-2113.
Read now
Read now
Jill A Ohar, Ayca Ozol-Godfrey, Thomas Goodin & Shahin Sanjar. (2020) Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 995-1004.
Read now
Read now
Irina R. Strâmbu, Zhanna D. Kobalava, Baldur P. Magnusson, Alastair MacKinnon & Jacqueline M. Parkin. (2019) Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:5-6, pages 344-353.
Read now
Read now
Vladimir Koblizek, Barbora Novotna, Zuzana Zbozinkova & Karel Hejduk. (2016) Diagnosing COPD: advances in training and practice – a systematic review. Advances in Medical Education and Practice 7, pages 219-231.
Read now
Read now
Articles from other publishers (33)
Mario Cazzola, Paola RoglianiPeter J. BarnesFrancesco BlasiBartolome Celli, Nicola A. HananiaFernando J. MartinezBruce E. MillerMarc Miravitlles, Clive P. PageRuth Tal-Singer & Maria Gabriella Matera. (2023) An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials. American Journal of Respiratory and Critical Care Medicine 208:4, pages 374-394.
Crossref
Crossref
Louise Newton, Oliver Knight-West, Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, Tara Symonds, David S. Reasner, Bill Byrom, Paul O’Donohoe & Susan Vallow. (2022) Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings. Journal of Patient-Reported Outcomes 6:1.
Crossref
Crossref
Stacie Hudgens, Louise Newton, Sonya Eremenco, Mabel Crescioni, Tara Symonds, Philip C. G. Griffiths, David S. Reasner, Bill Byrom, Paul O’Donohoe & Susan Vallow. (2022) Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings. Journal of Patient-Reported Outcomes 6:1.
Crossref
Crossref
Maggie Tabberer, Robyn von Maltzahn, Elizabeth D. Bacci, Hayley Karn, Ray Hsieh, Timothy A. Howell, Zelie Bailes, Andrew Fowler, Laurie Lee & Lindsey T. Murray. (2021) Measuring respiratory symptoms in moderate/severe asthma: evaluation of a respiratory symptom tool, the E-RS®: COPD in asthma populations. Journal of Patient-Reported Outcomes 5:1.
Crossref
Crossref
Ja Yun Choi, Maureen George & So Young Yun. (2021) Development of a smartphone application for Korean patients with chronic obstructive pulmonary disease: Self-monitoring based action plans. Applied Nursing Research 61, pages 151475.
Crossref
Crossref
Christine R. Jenkins. (2021) Towards precision in defining COPD exacerbations. Breathe 17:3, pages 210081.
Crossref
Crossref
Fernando J. Martinez, Klaus F. Rabe, Gary T. Ferguson, Jadwiga A. Wedzicha, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius & Paul Dorinsky. (2021) Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. Respiratory Medicine 185, pages 106509.
Crossref
Crossref
Soo Kyung Park, Cho Hee Bang & Seung Hyeun Lee. (2020) Evaluating the effect of a smartphone app-based self-management program for people with COPD: A randomized controlled trial. Applied Nursing Research 52, pages 151231.
Crossref
Crossref
Anthony Windmon, Sriram Chellappan & Ponrathi R. Athilingam. 2020. Mobile Computing, Applications, and Services. Mobile Computing, Applications, and Services
102
120
.
Spencer Phillips Hey, Aaron S. Kesselheim, Pranav Patel, Preeti Mehrotra & John H. PowersIIIIII. (2020) US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals. JAMA Internal Medicine 180:1, pages 131.
Crossref
Crossref
Edward M. Kerwin, Gary T. Ferguson, Mindy Mo, Kiernan DeAngelis & Paul Dorinsky. (2019) Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study. Respiratory Research 20:1.
Crossref
Crossref
Eva Germovsek, Claire Ambery, Shuying Yang, Misba Beerahee, Mats O. Karlsson & Elodie L. Plan. (2019) A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients. The AAPS Journal 21:4.
Crossref
Crossref
Samantha Louise Harrison, Tamara Araujo, Roger Goldstein & Dina Brooks. (2019) Balance Measures Over 12 Months in Individuals With Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation and Prevention 39:3, pages E21-E24.
Crossref
Crossref
Linda Nelsen, Adam Gater, Charlotte Panter, Chloe Tolley, Laurie Lee & Steven Pascoe. (2018) Understanding and measuring symptoms and health status in asthma COPD overlap: content validity of the EXACT and SGRQ. Journal of Patient-Reported Outcomes 2:1.
Crossref
Crossref
Victor Kim & Shawn D. Aaron. (2018) What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. European Respiratory Journal 52:5, pages 1801261.
Crossref
Crossref
Donald A. Mahler & Sanjay Sethi. (2018) To Improve COPD Care. Chest 154:2, pages 235-237.
Crossref
Crossref
Alberto Papi, Jørgen Vestbo, Leonardo Fabbri, Massimo Corradi, Hélène Prunier, Géraldine Cohuet, Alessandro Guasconi, Isabella Montagna, Stefano Vezzoli, Stefano Petruzzelli, Mario Scuri, Nicolas Roche & Dave Singh. (2018) Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. The Lancet 391:10125, pages 1076-1084.
Crossref
Crossref
Elizabeth Dansie Bacci, Sean O'Quinn, Nancy Kline Leidy, Lindsey Murray & Margaret Vernon. (2018) Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis. Respiratory Medicine 134, pages 130-138.
Crossref
Crossref
Paul Kamudoni, Nutjaree Johns & Sam SalekPaul Kamudoni, Nutjaree Johns & Sam Salek. 2018. Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Living with Chronic Disease: Measuring Important Patient-Reported Outcomes
15
49
.
Drishty D Sobnath, Nada Philip, Reem Kayyali, Shereen Nabhani-Gebara, Barbara Pierscionek, Anouk W Vaes, Martijn A Spruit & Evangelos Kaimakamis. (2017) Features of a Mobile Support App for Patients With Chronic Obstructive Pulmonary Disease: Literature Review and Current Applications. JMIR mHealth and uHealth 5:2, pages e17.
Crossref
Crossref
Philip E Silkoff, Dave Singh, J Mark FitzGerald, Andreas Eich, Andrea Ludwig-Sengpiel, Geoffrey C Chupp, Vibeke Backer, Celeste Porsbjerg, Pierre-Olivier Girodet, Mark T Dransfield, Frederic Baribaud, Vedrana S Susulic & Matthew J Loza. (2017) Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation. Biomarker Insights 12, pages 117727191773030.
Crossref
Crossref
Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri & Jørgen Vestbo. (2016) Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. The Lancet 388:10048, pages 963-973.
Crossref
Crossref
Bruce E. Miller, Ruth Tal-Singer, Stephen I. Rennard, Armin Furtwaengler, Nancy Leidy, Michael Lowings, Ubaldo J. Martin, Thomas R. Martin, Debora D. Merrill, Jeffrey Snyder, John Walsh & David M. Mannino. (2016) Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. American Journal of Respiratory and Critical Care Medicine 193:6, pages 607-613.
Crossref
Crossref
Eric D. Bateman, Kenneth R. Chapman, Dave Singh, Anthony D. D’Urzo, Eduard Molins, Anne Leselbaum & Esther Garcia Gil. (2015) Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respiratory Research 16:1.
Crossref
Crossref
Sam Salek & Paul Kamudoni. (2015) Streamlining the Validation of Patient Reported Outcome (PRO) Measures in Drug Regulatory Processes. Pharmaceutical Medicine 29:5, pages 255-268.
Crossref
Crossref
Ad A Kaptein, Frans Meulenberg & Joshua M Smyth. (2015) A breath of fresh air: Images of respiratory illness in novels, poems, films, music, and paintings. Journal of Health Psychology 20:3, pages 246-258.
Crossref
Crossref
Jinkyeong Park, Jung Su LeeChinkook Rhee & Yeon-Mok Oh. (2015) Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials. Journal of Korean Medical Science 30:10, pages 1453.
Crossref
Crossref
Nancy K Leidy, Lindsey T Murray, Brigitta U Monz, Linda Nelsen, Mitchell Goldman, Paul W Jones, Elizabeth J Dansie & Sanjay Sethi. (2014) Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials. Respiratory Research 15:1.
Crossref
Crossref
Anthony D D’Urzo, Stephen I Rennard, Edward M Kerwin, Victor Mergel, Anne R Leselbaum & Cynthia F Caracta. (2014) Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respiratory Research 15:1.
Crossref
Crossref
Dave Singh, Paul W Jones, Eric D Bateman, Stephanie Korn, Cristina Serra, Eduard Molins, Cynthia Caracta, Esther Garcia Gil & Anne Leselbaum. (2014) Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Hana Müllerová, Amit Shukla, Adam Hawkins & Jennifer Quint. (2014) Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open 4:12, pages e006171.
Crossref
Crossref
Nancy K. Leidy, Lindsey T. Murray, Paul Jones & Sanjay Sethi. (2014) Performance of the EXAcerbations of Chronic Pulmonary Disease Tool Patient-reported Outcome Measure in Three Clinical Trials of Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 11:3, pages 316-325.
Crossref
Crossref
Susan J. Bartlett, Teresa Barnes & R. Andrew McIvor. (2014) Integrating Patients into Meaningful Real-World Research. Annals of the American Thoracic Society 11:Supplement 2, pages S112-S117.
Crossref
Crossref